ORIGINAL RESEARCH article
Front. Immunol.
Sec. Microbial Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1592597
This article is part of the Research TopicModulation of Pulmonary Immunity and Function by Bacterial and Host MetabolitesView all 7 articles
Revealing the impact of Pseudomonas aeruginosa quorum sensing molecule 2'aminoacetophenone on the human bronchial-airway epithelium and pulmonary endothelium using a human airway-on-a-chip
Provisionally accepted- 1Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
- 2Department of Microbiology, Harvard Medical School, Boston, United States
- 3Shriners Children's Boston, Boston, Massachusetts, United States
- 4Regeneron Pharmaceuticals, New York, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Pseudomonas aeruginosa (PA) causes severe respiratory infections utilizing multiple virulence functions. Our earlier work demonstrated that the Pseudomonas aeruginosa quorum-sensing molecule 2′-aminoacetophenone (2-AA) reprograms host immune and metabolic pathways, thereby facilitating the pathogen's long-term persistence.However, its specific impact on the bronchial airway epithelium and pulmonary endothelium remains unknown. To evaluate the spatiotemporal changes in 2-AA within the human airway, considering endothelial cells as the primary point of contact when the route of lung infection is hematogenous, we utilized the airway-on-a-chip platform lined by polarized human bronchial airway epithelium and pulmonary endothelium.Using this platform, we performed RNA sequencing to analyse the responses of 2-AAtreated primary human pulmonary microvascular endothelial cells (HPMEC) and adjacent primary normal human bronchial epithelial cells (NHBE) from healthy female donors, as well as potential cross-talk between these cells. Analyses revealed that 2-AA differentially regulates specific signaling and biosynthesis pathways in epithelial cells, including HIF-1 and pyrimidine signaling, as well as glycosaminoglycan and glycosphingolipid biosynthesis. On the other hand, in endothelial cells, fatty acid metabolism, phosphatidylinositol signaling, estrogen receptor signaling, and inflammatory signaling pathways have been identified. Significant overlap was found in both cell types in response to 2-AA in genes implicated in immune response and cellular functions. In contrast, we found that genes related to barrier permeability, cholesterol metabolism, and oxidative phosphorylation were differentially regulated in response to 2-AA exposure in the studied cell types. Murine in-vivo and additional in vitro cell culture studies confirmed cholesterol accumulation in epithelial cells. Results also revealed that specific biomarkers associated with cystic fibrosis and idiopathic pulmonary fibrosis were modulated by 2-AA in both cell types, with the expression of cystic fibrosis transmembrane regulator being affected only in endothelial cells.The effects of 2-AA on epithelial and endothelial primary cells studied within a dynamic microphysiological environment that mimics the human lung airway deepen our understanding of this quorum sensing (QS) signaling molecule. This study offers novel insights into the functions and interactions of 2-AA, paving the way for innovative, cellspecific therapeutic strategies to combat Pseudomonas aeruginosa lung infections.
Keywords: Pseudomonas aeruginosa, PA14, 2'-Aminoacetophenone, 2-AA, mvfR, pqsR, MvfR/pqsABCDE system, Lung-on-chip
Received: 12 Mar 2025; Accepted: 17 Jun 2025.
Copyright: © 2025 Aggarwal, Chakraborty, Singh, Lory, Karalis and Rahme. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Laurence Rahme, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, Massachusetts, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.